Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 4.80M | 6.71M | 3.73M | -1.57M | -620.00K |
| Total Depreciation and Amortization | 22.96M | 23.27M | 25.02M | 24.80M | 25.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.03M | 17.84M | 12.01M | 17.83M | 14.27M |
| Change in Net Operating Assets | 5.89M | -4.99M | 771.00K | -150.00K | -709.00K |
| Cash from Operations | 55.67M | 42.83M | 41.53M | 40.91M | 37.96M |
| Capital Expenditure | -2.80M | -3.25M | -3.59M | -3.67M | -4.37M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -250.00K | -250.00K | -250.00K |
| Cash from Investing | -2.80M | -3.25M | -3.84M | -3.92M | -4.62M |
| Total Debt Issued | 107.00M | 107.50M | 107.50M | 107.50M | 10.50M |
| Total Debt Repaid | -145.47M | -134.25M | -137.50M | -138.25M | -42.25M |
| Issuance of Common Stock | -- | -- | 2.64M | 2.64M | 2.64M |
| Repurchase of Common Stock | -2.02M | -2.12M | -1.95M | -1.95M | -1.95M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.53M | -3.52M | -3.51M | -3.49M | -3.48M |
| Other Financing Activities | 95.00K | -9.46M | -9.48M | -9.24M | -8.98M |
| Cash from Financing | -43.93M | -41.85M | -42.29M | -42.79M | -43.52M |
| Foreign Exchange rate Adjustments | 467.00K | 1.88M | 2.61M | 1.89M | 2.98M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.42M | -393.00K | -1.98M | -3.92M | -7.19M |